These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6289935)

  • 21. Polio's last stand.
    Clarke T
    Nature; 2001 Jan; 409(6818):278-80. PubMed ID: 11201713
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
    Horaud F
    Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antimutagenic action of cellular and humoral immunity factors in cytogenetic disorders of cultured fibroblasts induced by a vaccinal strain of the measles virus].
    Il'inskikh NN
    Tsitologiia; 1982 Jun; 24(6):726-30. PubMed ID: 6981873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
    Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
    Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential use of viral genomic markers in estimating the neurovirulence of oral poliomyelitis vaccine (OPV): regulatory aspects.
    Fenyves A
    Dev Biol Stand; 1993; 78():157-9. PubMed ID: 8388826
    [No Abstract]   [Full Text] [Related]  

  • 27. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
    Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
    Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
    Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Nagata N; Kew O; Miyamura T
    Dev Biol (Basel); 2001; 105():93-8. PubMed ID: 11763343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating vaccine-derived polioviruses: current state of knowledge.
    Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
    Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic changes in strains of poliovirus type 2 isolated from patients with vaccine-associated paralytic poliomyelitis].
    Sosa-Díaz RY; Más-Lago P; Valdés-Ramírez O; Sarmiento-Pérez L
    Rev Neurol; 2003 May 1-15; 36(9):812-6. PubMed ID: 12717666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
    Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
    Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns.
    Roberts L
    Science; 2007 Sep; 317(5846):1842. PubMed ID: 17901301
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P; Tabatabaie H; Gouya MM; Zahraie M; Mahmudi M; Ziaie A; Rad KS; Shahmahmudi Sh; Musavi T; Azad TM; Nategh R
    J Clin Virol; 2007 Aug; 39(4):304-7. PubMed ID: 17590391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative characteristics of different methods of studying the cytogenetic disturbances in the bone marrow cells of Macaca rhesus monkeys infected with the poliomyelitis virus].
    Il'inskikh NN; Il'inskikh IN
    Genetika; 1982 May; 18(5):764-7. PubMed ID: 7047302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spontaneous and induced chromosome aberrations in the bone marrow cells of different strains of mice during aging].
    Lil'p IG; Korogodina IuV
    Tsitologiia; 1981 Oct; 23(10):1174-9. PubMed ID: 6797115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
    Friedrich F
    Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious diseases. Polio outbreak raises questions about vaccine.
    Greensfelder L
    Science; 2000 Dec; 290(5498):1867-9. PubMed ID: 11187033
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(28):641-3. PubMed ID: 9233551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.